{
  "SimulationMappings": [
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_2mgkg_Kd_fit",
      "Path": "Tefibazumab/Tefibazumab_2mgkg_Kd_fit/",
      "SimulationFile": "Tefibazumab_2mgkg_Kd_fit"
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_5mgkg_Kd_fit",
      "Path": "Tefibazumab/Tefibazumab_5mgkg_Kd_fit/",
      "SimulationFile": "Tefibazumab_5mgkg_Kd_fit"
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_10mgkg_Kd_fit",
      "Path": "Tefibazumab/Tefibazumab_10mgkg_Kd_fit/",
      "SimulationFile": "Tefibazumab_10mgkg_Kd_fit"
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_20mgkg_Kd_fit",
      "Path": "Tefibazumab/Tefibazumab_20mgkg_Kd_fit/",
      "SimulationFile": "Tefibazumab_20mgkg_Kd_fit"
    }
  ],
  "ObservedDataSets": [
    {
      "Id": "Reilley2005_tefibazumab_PKSimImport.Dose10",
      "Path": "ObservedData/Reilley2005_tefibazumab_PKSimImport.Dose10.csv"
    },
    {
      "Id": "Reilley2005_tefibazumab_PKSimImport.Dose2",
      "Path": "ObservedData/Reilley2005_tefibazumab_PKSimImport.Dose2.csv"
    },
    {
      "Id": "Reilley2005_tefibazumab_PKSimImport.Dose20",
      "Path": "ObservedData/Reilley2005_tefibazumab_PKSimImport.Dose20.csv"
    },
    {
      "Id": "Reilley2005_tefibazumab_PKSimImport.Dose5",
      "Path": "ObservedData/Reilley2005_tefibazumab_PKSimImport.Dose5.csv"
    }
  ],
  "Plots": {
    "AxesSettings": {
      "GOFMergedPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Concentration (molar)",
          "Unit": "µmol/l",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (molar)",
          "Unit": "µmol/l",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "GOFMergedPlotsResidualsOverTime": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Linear"
        }
      ],
      "ComparisonTimeProfile": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (molar)",
          "Unit": "µmol/l",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsResidualsVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "PKRatioPlots": [
        {
          "Type": "X",
          "Dimension": "Age",
          "Unit": "year(s)",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ]
    },
    "PlotSettings": {
      "ChartWidth": 500,
      "ChartHeight": 400,
      "Fonts": {
        "AxisSize": 11,
        "LegendSize": 9,
        "OriginSize": 9,
        "FontFamilyName": "Arial",
        "WatermarkSize": 40
      }
    },
    "GOFMergedPlots": [
      {
        "Title": "Goodness of fit plot for concentration in plasma",
        "SectionReference": "diagnostics-plots",
        "Artifacts": [
          "Plot",
          "GMFE",
          "Measure"
        ],
        "PlotTypes": [
          "predictedVsObserved",
          "residualsOverTime"
        ],
        "Groups": [
          {
            "Caption": "2 mg/kg dose",
            "Symbol": "Circle",
            "OutputMappings": [
              {
                "Project": "Tefibazumab",
                "Simulation": "Tefibazumab_2mgkg_Kd_fit",
                "Output": "Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose2",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "5 mg/kg dose",
            "Symbol": "Square",
            "OutputMappings": [
              {
                "Project": "Tefibazumab",
                "Simulation": "Tefibazumab_5mgkg_Kd_fit",
                "Output": "Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose5",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "10 mg/kg dose",
            "Symbol": "Diamond",
            "OutputMappings": [
              {
                "Project": "Tefibazumab",
                "Simulation": "Tefibazumab_10mgkg_Kd_fit",
                "Output": "Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose10",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "20 mg/kg dose",
            "Symbol": "Triangle",
            "OutputMappings": [
              {
                "Project": "Tefibazumab",
                "Simulation": "Tefibazumab_20mgkg_Kd_fit",
                "Output": "Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose20",
                "Color": "#FF0000"
              }
            ]
          }
        ]
      }
    ],
    "ComparisonTimeProfilePlots": [],
    "DDIRatioPlots": [],
    "PKRatioPlots": [],
    "TimeProfile": [
      {
        "Project": "Tefibazumab",
        "Simulation": "Tefibazumab_2mgkg_Kd_fit",
        "SectionReference": "ct-profiles",
        "Plot": {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_2mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 2 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose2|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 2 mg/kg dose (linear scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_2mgkg_Kd_fit\n2023-03-07 10:08"
        }
      },
      {
        "Project": "Tefibazumab",
        "Simulation": "Tefibazumab_2mgkg_Kd_fit",
        "SectionReference": "ct-profiles",
        "Plot": {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_2mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 2 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose2|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 2 mg/kg dose (log scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_2mgkg_Kd_fit\n2023-03-07 10:08"
        }
      },
      {
        "Project": "Tefibazumab",
        "Simulation": "Tefibazumab_5mgkg_Kd_fit",
        "SectionReference": "ct-profiles",
        "Plot": {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_5mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 5 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose5|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 5 mg/kg dose (linear scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_5mgkg_Kd_fit\n2023-03-07 10:08"
        }
      },
      {
        "Project": "Tefibazumab",
        "Simulation": "Tefibazumab_5mgkg_Kd_fit",
        "SectionReference": "ct-profiles",
        "Plot": {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_5mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 5 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose5|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 5 mg/kg dose (log scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_5mgkg_Kd_fit\n2023-03-07 10:08"
        }
      },
      {
        "Project": "Tefibazumab",
        "Simulation": "Tefibazumab_10mgkg_Kd_fit",
        "SectionReference": "ct-profiles",
        "Plot": {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_10mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 10 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose10|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 10 mg/kg dose (linear scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_10mgkg_Kd_fit\n2023-03-07 10:08"
        }
      },
      {
        "Project": "Tefibazumab",
        "Simulation": "Tefibazumab_10mgkg_Kd_fit",
        "SectionReference": "ct-profiles",
        "Plot": {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_10mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 10 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose10|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 10 mg/kg dose (log scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_10mgkg_Kd_fit\n2023-03-07 10:08"
        }
      },
      {
        "Project": "Tefibazumab",
        "Simulation": "Tefibazumab_20mgkg_Kd_fit",
        "SectionReference": "ct-profiles",
        "Plot": {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_20mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 20 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose20|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 20 mg/kg dose (linear scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_20mgkg_Kd_fit\n2023-03-07 10:08"
        }
      },
      {
        "Project": "Tefibazumab",
        "Simulation": "Tefibazumab_20mgkg_Kd_fit",
        "SectionReference": "ct-profiles",
        "Plot": {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_20mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 20 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose20|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 20 mg/kg dose (log scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_20mgkg_Kd_fit\n2023-03-07 10:08"
        }
      }
    ]
  },
  "Inputs": [
    {
      "SectionReference": "final-input-parameters",
      "Path": "Inputs/Tefibazumab/Compound/Tefibazumab.md"
    }
  ],
  "Sections": [
    {
      "Reference": "introduction",
      "Title": "Introduction",
      "Content": "Content/Section1_Introduction.md",
      "Sections": []
    },
    {
      "Reference": "methods",
      "Title": "Methods",
      "Sections": [
        {
          "Reference": "modeling-strategy",
          "Title": "Modeling Strategy",
          "Content": "Content/Section2.1_Modeling_Strategy.md",
          "Sections": []
        },
        {
          "Reference": "methods-data",
          "Title": "Data",
          "Content": "Content/Section2.2_Data.md",
          "Sections": []
        },
        {
          "Reference": "model-parameters-and-assumptions",
          "Title": "Model Parameters and Assumptions",
          "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md",
          "Sections": []
        }
      ]
    },
    {
      "Reference": "results-and-discussion",
      "Title": "Results and Discussion",
      "Content": "Content/Section3_Results_and_Discussion.md",
      "Sections": [
        {
          "Reference": "final-input-parameters",
          "Title": "Final input parameters",
          "Content": "Content/Input_table.md",
          "Sections": []
        },
        {
          "Reference": "diagnostics-plots",
          "Title": "Diagnostics Plots",
          "Content": "Content/GOF_diagnostics.md",
          "Sections": []
        },
        {
          "Reference": "ct-profiles",
          "Title": "Concentration-Time Profiles",
          "Content": "Content/Concentration_time_profiles.md",
          "Sections": []
        }
      ]
    },
    {
      "Reference": "conclusion",
      "Title": "Conclusion",
      "Content": "Content/Conclusion.md",
      "Sections": []
    },
    {
      "Reference": "main-references",
      "Title": "References",
      "Content": "Content/References.md",
      "Sections": []
    }
  ],
  "Intro": [
    {
      "Path": "Intro/titlepage.md"
    }
  ]
}